Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: A population-based cohort study of older adults

Journal of Clinical Psychiatry

Volumn 70, Issue 12, 2009, Pages 1681-1686

  Shulman, Kenneth I ^a,b   Fischer, Hadas D ^c   Herrmann, Nathan ^b   Huo, Cindy Yan ^c   Anderson, Geoffrey M ^c,e   Rochon, Paula A ^a,c,d,e  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d WOMEN S COLLEGE HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIVASTINE; ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEPRAMONE; AMPHETAMINE; BENZPHETAMINE; BROMFED; BUSPIRONE; CITALOPRAM; COCAINE; CYCLOMYDRIL; DEXAMPHETAMINE; DEXMETHYLPHENIDATE; DEXTROAMP; DEXTROMETHORPHAN; DOPAMINE; DULOXETINE; EPHEDRINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; ISOMETHEPTENE; MAZINDOL; METARAMINOL; METHAMPHETAMINE; METHYLPHENIDATE; MIRTAZAPINE; PARACETAMOL PLUS TRAMADOL; PAROXETINE; PETHIDINE; PHENDIMETRAZINE TARTRATE; PHENELZINE; PROMETH; PROMETHAZINE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SIBUTRAMINE; TRAMADOL; TRANYLCYPROMINE; TRAZODONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENLAFAXINE;

AGED; ARTICLE; CANADA; COHORT ANALYSIS; DRUG CONTRAINDICATION; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; HYPERTENSIVE CRISIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OBSERVATIONAL STUDY; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RECURRENT DISEASE; SEROTONIN SYNDROME;

AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; COHORT STUDIES; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DRUG INTERACTIONS; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MONOAMINE OXIDASE INHIBITORS; ONTARIO; PHYSICIAN'S PRACTICE PATTERNS; SAFETY; SEROTONIN SYNDROME;

EID: 74549210350     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.08m05041blu     Document Type: Article

References (24)

1. Andrews JM, Nemeroff CB. Contemporary management of depression. Am J Med. 1994;97(6A):s24-s32. doi:10.1016/0002-9343(94)90360-3
2. Blackwell B. Hypertensive crisis due to monoamine-oxidase inhibitors. Lancet. 1963;2(7313):849-850. PubMed doi:10.1016/S0140-6736(63)92743-0
3. McGrath PJ, Stewart JW, Quitkin FM. The use of monoamine oxidase inhibitors for treating atypical depression. Psychiatr Ann. 2001;31:371-375.
4. Thase ME. Recognition and diagnosis of atypical depression. J Clin Psychiatry. 2007;68(suppl 8):11-16. PubMed
5. Nemeroff CB. Prevalence and management of treatment-resistant depression. J Clin Psychiatry. 2007;68(suppl 8):17-25. PubMed
6. Georgotas A, McCue RE, Friedman E, et al. Relationship of platelet MAO activity to characteristics of major depressive illness. Psychiatry Res. 1986;19(4):247-256. PubMed doi:10.1016/0165-1781(86)90118-6
7. Krishnan KR. Revisiting monoamine oxidase inhibitors. J Clin Psychiatry. 2007;68(suppl 8):35-41. PubMed
8. Gardner DM, Shulman KI, Walker SE, et al. The making of a user friendly MAOI diet. J Clin Psychiatry. 1996;57(3):99-104. PubMed
9. Shulman KI, Walker SE. A reevaluation of dietary restrictions for irreversible monoamine oxidase inhibitors. Psychiatr Ann. 2001;31:378-384.
10. Angst J, Amrein R, Stabl M. Moclobemide and tricyclic antidepressants in severe depression: meta-analysis and prospective studies. J Clin Psychopharmacol. 1995;15(suppl 2): 16S-23S. PubMed doi:10.1097/00004714- 199508001-00004
11. Amsterdam JD. A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder. J Clin Psychiatry. 2003;64(2):208-214. PubMed
12. American Psychiatric Association. Practice Guidelines for the Treatment of Patients With Major Depressive Disorder (Revision). Am J Psychiatry. 2000;157(suppl 4):1-45.
13. Yatham LN, Kennedy SH, O'Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord. 2005;7(suppl 3):5-69. PubMed doi:10.1111/j.1399-5618.2005.00188.x
14. Suppes T, Dennehy EB, Hirschfeld RM, et al. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry. 2005;66(7):870-886. PubMed
15. Goodwin GM. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2003;17(2):149-173 [discussion 147]. PubMed doi:10.1177/0269881103017002003
16. Schneeweiss S, Seeger JD, Maclure M, et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001;154(9):854-864. PubMed doi:10.1093/aje/154.9.854
17. Hansten PD, Horn JR. The Top 100 Drug Interactions: A Guide to Patient Management. Freeland, WA: H & H Publications; 2007.
18. Mamdani M, Rapoport M, Shulman KI, et al. Mental health-related drug utilization among older adults: prevalence, trends, and costs. Am J Geriatr Psychiatry. 2005;13(10):892-900. PubMed
19. Shulman KI, Sykora K, Gill S, et al. Incidence of delirium in older adults newly prescribed lithium or valproate: a population-based cohort study. J Clin Psychiatry. 2005;66(4):424-427. PubMed
20. Robinson DS, Nies A. Demographic, biologic, and other variables affecting monoamine oxidase activity. Schizophr Bull. 1980;6(2):298-307. PubMed
21. Meyer JH, Ginovart N, Boovariwala A, et al. Elevated monoamine oxidase A levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry. 2006;63(11):1209-1216. PubMed doi:10.1001/archpsyc.63.11.1209
22. Rapaport MH. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art. J Clin Psychiatry. 2007;68(suppl 8):42-46. PubMed
23. Nolen WA, Kupka RW, Hellemann G, et al. Tranylcypromine vs lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatr Scand. 2007;115(5):360-365. PubMed doi:10.1111/j.1600-0447.2007.00993.x
24. Thase ME. Treatment of refractory bipolar depression. Curr Psychiatry Rep. 2007;9(6):495-496. PubMed doi:10.1007/s11920-007-0067-x